Fig. 4.
![Fig. 4. Dose-dependent effects of indinavir or saquinavir on T-cell proliferation and apoptosis. / Results represent the mean ± SD of [3H]-thymidine uptake (A and B) and percentage apoptotic cells upon TCR/CD3 ligation with anti-CD3 antibodies (C and D) or upon Fas ligation with anti-Fas antibodies (E and F) in 10 healthy donor PBMCs (□) and 10 untreated HIV-1 patient PBMCs (▪).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/96/1/10.1182_blood.v96.1.250/4/bloo01328004x.jpeg?Expires=1735588614&Signature=gMBOvsvFrC99T~xyc5mfiWOH~OA-9zZD-50-T1P427SSVcg5BLInMyHnnbZoaaUTUrtPtjk7kopjjG5SLYNJGaiexU~nBwdYfB2R487~xrA1VFzoslVGvq6P7YTpPuAjJ7icpzd6TCvonxgLX5XI0mwc7qwR~Y1kRgZO2crL6IC77aJ5uE7I8bo10e8mhds5ItwfiUxixwdh5wNhGV8BzcTgbeFFGD6oCL1tgylyKpvHgf01NN6Cx-kM-09uXuoF5i9zuKJKgFW61C2bRAKeLYemsrKWZDXsyI85SWALX9iu~PwBm1QSgxZExK2sTcX09YK59ReaUOuLqQ-Bx9x2fg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Dose-dependent effects of indinavir or saquinavir on T-cell proliferation and apoptosis.
Results represent the mean ± SD of [3H]-thymidine uptake (A and B) and percentage apoptotic cells upon TCR/CD3 ligation with anti-CD3 antibodies (C and D) or upon Fas ligation with anti-Fas antibodies (E and F) in 10 healthy donor PBMCs (□) and 10 untreated HIV-1 patient PBMCs (▪).
